tetano
Editor, Senior Moderator
Pulm Ther
. 2023 Mar 29.
doi: 10.1007/s41030-023-00219-x. Online ahead of print.
Guillain-Barré Syndrome due to COVID-19 Vero Cell Vaccination Associated with Concomitant COVID-19 Infection-induced ARDS and Treated Successfully by Therapeutic Plasma Exchange: A First Case Report from Vietnam
Sy Duong-Quy[SUP] 1 2 3 4 [/SUP], Duc Huynh-Truong-Anh[SUP] 5 [/SUP], Tien Nguyen-Quang[SUP] 5 [/SUP], Thanh Nguyen-Thi-Kim[SUP] 5 [/SUP], Thuy Tran-Ngoc-Anh[SUP] 5 [/SUP], Nam Nguyen-Van-Hoai[SUP] 5 [/SUP], Mai Do-Thi-Thu[SUP] 5 [/SUP], Tinh Nguyen-Van[SUP] 5 [/SUP], Tram Tang-Thi-Thao[SUP] 6 [/SUP], Anh Nguyen-Tuan[SUP] 6 [/SUP], Toi Nguyen-Van[SUP] 6 [/SUP], Quynh Tran-Xuan[SUP] 7 [/SUP], Quan Vu-Tran-Thien[SUP] 8 [/SUP], The Trinh-Du[SUP] 9 [/SUP], Tuan Tran-Thai[SUP] 9 [/SUP], Thai Nguyen-Duy[SUP] 10 [/SUP], Huong Tran-Van[SUP] 11 12 [/SUP], Anh Vo-Thi-Kim[SUP] 13 14 [/SUP]
Affiliations
Abstract
Post-vaccination adverse reactions have been reported with varying symptoms and severity owing to research and production time pressures during the coronavirus disease 2019 (COVID-19) pandemic. In this article, we report a rare case of Guillain-Barré syndrome (GBS) in a patient with COVID-19 with acute respiratory distress syndrome (ARDS) after receiving Sinopharm's Vero Cell vaccine (China). The patient who was initially negative for COVID-19 was diagnosed with GBS based on paralysis that developed from the lower extremities to the upper extremities, as confirmed by cytoalbuminologic dissociation in the cerebrospinal fluid. The patient's condition worsened with ARDS caused by COVID-19 infection during the hospital stay, and SpO[SUB]2[/SUB] decreased to 83% while receiving oxygen through a non-rebreather mask (15 l/min) on day 6. The patient was treated with standard therapy for severe COVID-19, invasive mechanical ventilation, and five cycles of therapeutic plasma exchange (TPE) with 5% albumin replacement on day 11 due to severe progression. The patient was weaned off the ventilator on day 28, discharged on day 42, and was completely healthy after 6 months without any neurological sequelae until now. Our report showed the potential of TPE for GBS treatment in critically ill patients with COVID-19 after COVID-19 vaccination.
Keywords: ARDS; Binh Duong; COVID-19; Guillain–Barré syndrome; SARS-CoV-2; Vaccination; Vero cell.
. 2023 Mar 29.
doi: 10.1007/s41030-023-00219-x. Online ahead of print.
Guillain-Barré Syndrome due to COVID-19 Vero Cell Vaccination Associated with Concomitant COVID-19 Infection-induced ARDS and Treated Successfully by Therapeutic Plasma Exchange: A First Case Report from Vietnam
Sy Duong-Quy[SUP] 1 2 3 4 [/SUP], Duc Huynh-Truong-Anh[SUP] 5 [/SUP], Tien Nguyen-Quang[SUP] 5 [/SUP], Thanh Nguyen-Thi-Kim[SUP] 5 [/SUP], Thuy Tran-Ngoc-Anh[SUP] 5 [/SUP], Nam Nguyen-Van-Hoai[SUP] 5 [/SUP], Mai Do-Thi-Thu[SUP] 5 [/SUP], Tinh Nguyen-Van[SUP] 5 [/SUP], Tram Tang-Thi-Thao[SUP] 6 [/SUP], Anh Nguyen-Tuan[SUP] 6 [/SUP], Toi Nguyen-Van[SUP] 6 [/SUP], Quynh Tran-Xuan[SUP] 7 [/SUP], Quan Vu-Tran-Thien[SUP] 8 [/SUP], The Trinh-Du[SUP] 9 [/SUP], Tuan Tran-Thai[SUP] 9 [/SUP], Thai Nguyen-Duy[SUP] 10 [/SUP], Huong Tran-Van[SUP] 11 12 [/SUP], Anh Vo-Thi-Kim[SUP] 13 14 [/SUP]
Affiliations
- PMID: 36991236
- DOI: 10.1007/s41030-023-00219-x
Abstract
Post-vaccination adverse reactions have been reported with varying symptoms and severity owing to research and production time pressures during the coronavirus disease 2019 (COVID-19) pandemic. In this article, we report a rare case of Guillain-Barré syndrome (GBS) in a patient with COVID-19 with acute respiratory distress syndrome (ARDS) after receiving Sinopharm's Vero Cell vaccine (China). The patient who was initially negative for COVID-19 was diagnosed with GBS based on paralysis that developed from the lower extremities to the upper extremities, as confirmed by cytoalbuminologic dissociation in the cerebrospinal fluid. The patient's condition worsened with ARDS caused by COVID-19 infection during the hospital stay, and SpO[SUB]2[/SUB] decreased to 83% while receiving oxygen through a non-rebreather mask (15 l/min) on day 6. The patient was treated with standard therapy for severe COVID-19, invasive mechanical ventilation, and five cycles of therapeutic plasma exchange (TPE) with 5% albumin replacement on day 11 due to severe progression. The patient was weaned off the ventilator on day 28, discharged on day 42, and was completely healthy after 6 months without any neurological sequelae until now. Our report showed the potential of TPE for GBS treatment in critically ill patients with COVID-19 after COVID-19 vaccination.
Keywords: ARDS; Binh Duong; COVID-19; Guillain–Barré syndrome; SARS-CoV-2; Vaccination; Vero cell.